Study finds SETD1B drives aggressive growth in FLT3-mutated acute myeloid leukemia (AML) (IMAGE)
Caption
This model illustrates how SETD1B promotes the expansion of H3K4me3 epigenetic marks and upregulates MYC expression, driving cytokine-independent cell growth in FLT3-mutated AML.
Credit
Dr. Takayuki Hoshii from Chiba University, Japan https://www.nature.com/articles/s41375-025-02638-y
Usage Restrictions
Credit must be given to the creator.
License
CC BY